NK-1 Receptor Antagonists: A New Generation of Anticancer Drugs

E-ISSN： 1875-5607|12|7|593-599

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.12, Iss.7, 2012-06, pp. : 593-599

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A New Frontier in the Treatment of Cancer: NK-1 Receptor Antagonists

Current Medicinal Chemistry, Vol. 17, Iss. 6, 2010-02 ,pp. : 504-516

Bentham Science Publishers

Access to resources Recommend Favorite

NK-1 Receptor Antagonists: A New Paradigm in Pharmacological Therapy

Current Medicinal Chemistry, Vol. 18, Iss. 12, 2011-04 ,pp. : 1820-1831

Bentham Science Publishers

Access to resources Recommend Favorite

NK-1 receptor antagonists as antitumor drugs: a survey of the literature from 2000 to 2011

By Muñoz Miguel Martinez-Armesto Juan Coveñas Rafael

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 7, 2012-07 ,pp. : 735-746

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological profiles of new orally active nonpeptide tachykinin NK 1 receptor antagonists

By Hosoki R. Yanagisawa M. Onishi Y. Yoshioka K. Otsuka M.

European Journal of Pharmacology, Vol. 341, Iss. 2, 1998-01 ,pp. : 235-241

Elsevier

Access to resources Recommend Favorite

NK 1 (substance P) receptor antagonists - why are they not analgesic in humans?

By Hill R.

Trends in Pharmacological Sciences, Vol. 21, Iss. 7, 2000-07 ,pp. : 244-246

Elsevier

Access to resources Recommend Favorite